Johnson Paula A
SEC insider (Form 3/4/5 filer). CIK 0001341161. Director at Maze Therapeutics, Inc. (MAZE) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 13, 2026. Located in NEW BRUNSWICK, NJ.
Companies Johnson Paula A has filed insider reports for
- Maze Therapeutics, Inc. (MAZE): Director
- JOHNSON & JOHNSON (JNJ): Director
Johnson Paula A
CIK: 0001341161
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 13, 2026MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
36K shares- - Apr 23, 2026JNJ
JOHNSON & JOHNSON
AwardDirectDeferred Share Units
975 shares- - Apr 24, 2025JNJ
JOHNSON & JOHNSON
AwardDirectDeferred Share Units
1.3K shares- - Aug 23, 2023JNJ
JOHNSON & JOHNSON
DispositionDirect11 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 13, 2026 |  MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 36,000 | - | - | Direct |
| Apr 23, 2026 |  JNJ JOHNSON & JOHNSON | Award Deferred Share Units | 975 | - | - | Direct |
| Apr 24, 2025 | JNJ JOHNSON & JOHNSON | Award Deferred Share Units | 1,316 | - | - | Direct |
| Aug 23, 2023 | JNJ JOHNSON & JOHNSON | Disposition | 11 | - | $0 | Direct |
1-4 of 4 transactions